Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Marketing in Brief: Christian Dior

This article was originally published in The Rose Sheet

Executive Summary

Christian Dior: Extending Fahrenheit men's scent with Soothing After Shave Gel, Daily Moisture Complex, Natural-Looking Self Tanner and Moisturizing Body Lotion and repackaging the line's six existing ancillary products. Two of the existing products have been reformulated; Moisturizing Shave Foam, which replaces Shaving Foam, is "richer, for a smoother, closer shave," while Body and Hair Shampoo has an "improved easier-to-rinse formula," Dior states. The packaging for the foam and shampoo, along with the talc, soap and deodorant spray and stick, is now red with glossy, navy blue caps. All the products cost $16 except for the aftershave gel and body lotion, which cost $20 for 1.7 oz. and 6.8 oz., respectively, and the moisture complex, which is priced at $22 for 1.7 oz...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS001649

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel